BACKGROUND: @entity1690 ( @entity1690 ) is approved for uncomplicated @entity354 . Multiple studies have shown @entity1690 to compare favorably to @entity11035 ( @entity11035 ) in terms of symptom control with results out to 5  years. The @entity1690 device itself, however, is an added cost to an anti-reflux surgery, and direct cost comparison studies have not been done between @entity1690 and @entity11035 . The aim of the study was to compare charges, complications, and outcome of @entity1690 versus @entity11035 at 1  year. METHODS: This is a retrospective analysis of all @entity1 who underwent @entity1690 or @entity11035 for the treatment of @entity354 between January 2010 and June 2013. @entity1 charges were collected for the surgical admission. We also collected data on 30-day complications and symptom control at 1  year assessed by @entity354 -HRQL score and PPI use. RESULTS: There were 119 @entity1 included in the study, 52 @entity1690 and 67 @entity11035 . There was no significant difference between the mean charges for @entity1690 and @entity11035 ( 48,491 vs.  50,111, p  =  0.506). There were significant differences in OR time (66  min @entity1690 vs. 82  min @entity11035 , p  <  0.01) and LOS (17  h @entity1690 vs. 38  h @entity11035 , p  <  0.01). At 1-year follow-up, mean @entity354 -HRQL was 4.3 for @entity1690 versus 5.1 for @entity11035 (p  =  0.47) and 85  % of @entity1690 @entity1 versus 92  % of @entity11035 @entity1 were free from PPIs (p  =  0.37). @entity1690 @entity1 reported less gas bloat symptoms (23 vs. 53  %, p   <=  0.01) and inability to belch (10 vs. 36  %, p   <=  0.01) and vomit (4 vs. 19  %, p   <=  0.01). CONCLUSION: The side effect profile of @entity1690 is better than @entity11035 as evidenced by less gas bloat and increase ability to belch and vomit. @entity11035 and @entity1690 are comparable in symptom control, safety, and overall hospital charges. The charge for the @entity1690 device is offset by less charges in other categories as a result of the shorter operative time and LOS.

Charges, outcomes, and complications: a comparison of magnetic sphincter augmentation versus @entity11035 for the treatment of XXXX .

@entity11035 :: ('MESH:C535647', 'Disease') :: ['LNF', 'laparoscopic Nissen fundoplication'] @entity1 :: ('9606', 'Species') :: ['patients', 'Patient'] @entity1690 :: ('MESH:D046628', 'Disease') :: ['MSA', 'Magnetic sphincter augmentation'] @entity354 :: ('MESH:D005764', 'Disease') :: ['GERD']
@entity354 :: (MESH:D005764,Disease) :: ['GERD']
